Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ONCOXIN® and Quality of Life in Cancer Patients in a Real World Setting Study

NCT03550482 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT03550482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03550482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ONCOXIN® and Quality of Life in Cancer Patients in a Real World Setting Study
Lead sponsor
Catalysis SL
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2017
Completion date
May 15, 2019
Enrollment
133 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer stage ii, gastric cancer stage iii, non-small cell lung cancer stage ii, non-small cell lung cancer stage iii